EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy
Importance of the field: Recent advances in the understanding of the oncogenesis of head and neck squamous cell carcinomas (HNSCC) have revealed multiple dysregulated signaling pathways. One frequently altered axis is the EGFR-PI3K-Akt-mTOR pathway. This pathway plays a central role in numerous cell...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
2011
|
| In: |
Expert opinion on therapeutic targets
Year: 2011, Volume: 15, Issue: 1, Pages: 63-74 |
| ISSN: | 1744-7631 |
| DOI: | 10.1517/14728222.2011.541440 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1517/14728222.2011.541440
|
| Author Notes: | Christian Freudlsperger, MD, DDS, Jeffrey R. Burnett, BS, Jay A. Friedman, PhD, Vishnu R. Kannabiran, BS, Zhong Chen, MD, PhD, and Carter Van Waes, MD, PhD |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1838570403 | ||
| 003 | DE-627 | ||
| 005 | 20230710094135.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230308s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1517/14728222.2011.541440 |2 doi | |
| 035 | |a (DE-627)1838570403 | ||
| 035 | |a (DE-599)KXP1838570403 | ||
| 035 | |a (OCoLC)1389738247 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Freudlsperger, Christian |d 1977- |e VerfasserIn |0 (DE-588)130275913 |0 (DE-627)589450751 |0 (DE-576)301504105 |4 aut | |
| 245 | 1 | 0 | |a EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas |b attractive targets for molecular-oriented therapy |c Christian Freudlsperger, MD, DDS, Jeffrey R. Burnett, BS, Jay A. Friedman, PhD, Vishnu R. Kannabiran, BS, Zhong Chen, MD, PhD, and Carter Van Waes, MD, PhD |
| 264 | 1 | |c 2011 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Autorenmanuskript, verfügbar in PMC 2012 Juli 18 | ||
| 500 | |a Online veröffentlicht: 26 Nov 2010 | ||
| 500 | |a Gesehen am 08.03.2023 | ||
| 520 | |a Importance of the field: Recent advances in the understanding of the oncogenesis of head and neck squamous cell carcinomas (HNSCC) have revealed multiple dysregulated signaling pathways. One frequently altered axis is the EGFR-PI3K-Akt-mTOR pathway. This pathway plays a central role in numerous cellular processes including metabolism, cell growth, apoptosis, survival and differentiation, which ultimately contributes to HNSCC progression. Areas covered in this review: Books, journals, databases and websites have been searched to provide a current review on the subject. What the reader will gain: This article reviews the current understanding of EGFR-PI3K-Akt-mTOR signaling in HNSCC, including the impact of both genetic and epigenetic alterations. This review further highlights the potential of targeting this signaling cascade as a promising therapeutic approach in the treatment of HNSCC. Take home message: Genetic alterations of several nodes within this pathway, including both genetic and epigenetic changes, leading to either oncogene activation or inactivation of tumor suppressors have frequently been implicated in HNSCC. Consequently, drugs that target the central nodes of this pathway have become attractive for molecular oriented cancer therapies. Numerous preclinical and clinical studies are being performed in HNSCC; however, more studies are still needed to better understand the biology of this pathway. | ||
| 650 | 4 | |a Akt | |
| 650 | 4 | |a EGFR | |
| 650 | 4 | |a head and neck squamous cell carcinoma | |
| 650 | 4 | |a mTOR | |
| 650 | 4 | |a PI3K | |
| 650 | 4 | |a targeted therapy | |
| 700 | 1 | |a Burnett, Jeffrey R |e VerfasserIn |4 aut | |
| 700 | 1 | |a Friedman, Jay A |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kannabiran, Vishnu R |e VerfasserIn |4 aut | |
| 700 | 1 | |a Chen, Zhong |e VerfasserIn |4 aut | |
| 700 | 1 | |a Van Waes, Carter |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on therapeutic targets |d Abingdon, Oxon : Routledge, Taylor & Francis, 2001 |g 15(2011), 1, Seite 63-74 |h Online-Ressource |w (DE-627)324531923 |w (DE-600)2028202-3 |w (DE-576)301538425 |x 1744-7631 |7 nnas |a EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas attractive targets for molecular-oriented therapy |
| 773 | 1 | 8 | |g volume:15 |g year:2011 |g number:1 |g pages:63-74 |g extent:12 |a EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas attractive targets for molecular-oriented therapy |
| 856 | 4 | 0 | |u https://doi.org/10.1517/14728222.2011.541440 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230308 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 130275913 |a Freudlsperger, Christian |m 130275913:Freudlsperger, Christian |d 910000 |d 910800 |e 910000PF130275913 |e 910800PF130275913 |k 0/910000/ |k 1/910000/910800/ |p 1 |x j | ||
| 999 | |a KXP-PPN1838570403 |e 4284692682 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"note":["Gesehen am 07.11.24"],"title":[{"title":"Expert opinion on therapeutic targets","title_sort":"Expert opinion on therapeutic targets"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["324531923"],"issn":["1744-7631"],"zdb":["2028202-3"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"324531923","titleAlt":[{"title":"ETT"}],"part":{"issue":"1","extent":"12","text":"15(2011), 1, Seite 63-74","year":"2011","pages":"63-74","volume":"15"},"origin":[{"dateIssuedDisp":"2001-","publisher":"Routledge, Taylor & Francis ; Informa Healthcare","publisherPlace":"Abingdon, Oxon ; London [u.a.]","dateIssuedKey":"2001"}],"pubHistory":["Volume 5, issue 3 (2001)-"],"disp":"EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas attractive targets for molecular-oriented therapyExpert opinion on therapeutic targets"}],"name":{"displayForm":["Christian Freudlsperger, MD, DDS, Jeffrey R. Burnett, BS, Jay A. Friedman, PhD, Vishnu R. Kannabiran, BS, Zhong Chen, MD, PhD, and Carter Van Waes, MD, PhD"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"display":"Freudlsperger, Christian","family":"Freudlsperger","roleDisplay":"VerfasserIn","role":"aut","given":"Christian"},{"roleDisplay":"VerfasserIn","family":"Burnett","display":"Burnett, Jeffrey R","role":"aut","given":"Jeffrey R"},{"role":"aut","given":"Jay A","display":"Friedman, Jay A","family":"Friedman","roleDisplay":"VerfasserIn"},{"given":"Vishnu R","role":"aut","roleDisplay":"VerfasserIn","family":"Kannabiran","display":"Kannabiran, Vishnu R"},{"roleDisplay":"VerfasserIn","display":"Chen, Zhong","family":"Chen","given":"Zhong","role":"aut"},{"given":"Carter","role":"aut","roleDisplay":"VerfasserIn","display":"Van Waes, Carter","family":"Van Waes"}],"title":[{"title_sort":"EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas","title":"EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas","subtitle":"attractive targets for molecular-oriented therapy"}],"note":["Autorenmanuskript, verfügbar in PMC 2012 Juli 18","Online veröffentlicht: 26 Nov 2010","Gesehen am 08.03.2023"],"recId":"1838570403","physDesc":[{"extent":"12 S."}],"id":{"doi":["10.1517/14728222.2011.541440"],"eki":["1838570403"]},"language":["eng"]} | ||
| SRT | |a FREUDLSPEREGFRPI3KAK2011 | ||